224 related articles for article (PubMed ID: 9393780)
1. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin.
Guidry JJ; Cárdenas L; Cheng E; Clements JD
Infect Immun; 1997 Dec; 65(12):4943-50. PubMed ID: 9393780
[TBL] [Abstract][Full Text] [Related]
2. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
Dickinson BL; Clements JD
Infect Immun; 1995 May; 63(5):1617-23. PubMed ID: 7729864
[TBL] [Abstract][Full Text] [Related]
4. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
5. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
Bowman CC; Clements JD
Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.
de Haan L; Feil IK; Verweij WR; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Eur J Immunol; 1998 Apr; 28(4):1243-50. PubMed ID: 9565364
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb.
Fukuta S; Magnani JL; Twiddy EM; Holmes RK; Ginsburg V
Infect Immun; 1988 Jul; 56(7):1748-53. PubMed ID: 3290106
[TBL] [Abstract][Full Text] [Related]
8. Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxin.
Minke WE; Hong F; Verlinde CL; Hol WG; Fan E
J Biol Chem; 1999 Nov; 274(47):33469-73. PubMed ID: 10559230
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.
Norton EB; Lawson LB; Freytag LC; Clements JD
Clin Vaccine Immunol; 2011 Apr; 18(4):546-51. PubMed ID: 21288994
[TBL] [Abstract][Full Text] [Related]
12. Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists.
Minke WE; Roach C; Hol WG; Verlinde CL
Biochemistry; 1999 May; 38(18):5684-92. PubMed ID: 10231518
[TBL] [Abstract][Full Text] [Related]
13. The heat-labile enterotoxin of Escherichia coli binds to polylactosaminoglycan-containing receptors in CaCo-2 human intestinal epithelial cells.
Orlandi PA; Critchley DR; Fishman PH
Biochemistry; 1994 Nov; 33(43):12886-95. PubMed ID: 7947695
[TBL] [Abstract][Full Text] [Related]
14. Host response to Escherichia coli heat-labile enterotoxin via two microvillus membrane receptors in the rat intestine.
Zemelman BV; Chu SH; Walker WA
Infect Immun; 1989 Oct; 57(10):2947-52. PubMed ID: 2674013
[TBL] [Abstract][Full Text] [Related]
15. GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant.
Zoeteweij JP; Epperson DE; Porter JD; Zhang CX; Frolova OY; Constantinides AP; Fuhrmann SR; El-Amine M; Tian JH; Ellingsworth LR; Glenn GM
J Immunol; 2006 Jul; 177(2):1197-207. PubMed ID: 16818778
[TBL] [Abstract][Full Text] [Related]
16. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.
Nashar TO; Webb HM; Eaglestone S; Williams NA; Hirst TR
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):226-30. PubMed ID: 8552610
[TBL] [Abstract][Full Text] [Related]
17. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
Cheng E; Cárdenas-Freytag L; Clements JD
Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
[TBL] [Abstract][Full Text] [Related]
18. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
[TBL] [Abstract][Full Text] [Related]
19. Recombinant enterotoxins as vaccines against Escherichia coli-mediated diarrhoea.
Aitken R; Hirst TR
Vaccine; 1993; 11(2):227-33. PubMed ID: 8438620
[TBL] [Abstract][Full Text] [Related]
20. Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin.
Park EJ; Chang JH; Kim JS; Chung SI; Yum JS
Exp Mol Med; 1999 Jun; 31(2):101-7. PubMed ID: 10410310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
